Marleen van den Horst
Marleen van den Horst is partner in the IP and Technology practice group and heads the industry group Healthcare and Life Sciences. Marleen has more than 25 years of experience in conducting complex, cross-border proceedings on intellectual property. Specialised in patent law, she handles cases involving mechanical engineering, electrical engineering, chemistry and life sciences. From ship shutters, electronic Braille cells, floating solar panels, telecoms UMTS and LTE standard essential patents , machines for the manufacture of PVC-O pipes to medical equipment and pharmaceuticals. Marleen has achieved international recognition in the field of Life Sciences. In recent years, she has litigated and advised on patent and administrative litigation concerning, among other things, drugs whose active ingredients are ciclosporin, (es)omeprazole alendronate, escitalopram, modafinil, tramadol/paracetamol, glatiramer acetate, trastuzumab, zoledronate, rivastigmine, lenalidomide, ezetimibe+simvastatin, dasatinib, pemetrexed and sitagliptin as well as on CRISPR-Cas9 technology. Aside from litigation, Marleen also assists clients in negotiating and drawing up licences, technology transfers and distribution and cooperation agreements.
Selected directory listings
‘Working with Marleen van den Horst is a pleasant experience’. – Legal 500, 2022
With enthusiasm and skill, Marleen van den Horst clearly shows why she rightly belongs at the top in the Netherlands’. – Legal 500, 2022
‘Marleen van den Horst is very pragmatic and strong on regulatory issues’. – Legal 500, 2022
Clients appreciates that she is “straight to the point in addressing client needs” and expands that she “doesn’t get lost in non-relevant things“. – Chambers Europe, 2022
Van den Horst has a similar penchant for advanced technologies and complicated cases, particularly in the life sciences. “In addition to the expertise she brings, I am also very impressed by the quality of Marleen’s efforts and her motivation to continuously support us in realising our dream,” reports one client. “We fought our case in multiple jurisdictions and Marleen’s defence was tried, tested and true.” – IAM Patent 1000, 2021
Marleen van den Horst is recognized as Leading Individual in the area of Healthcare & Life sciences, It’s great to work with lawyers who not only have top legal insight and knowledge, but also a genuinely commercial approach’. – Legal 500, 2021
“Marleen van den Horst is highly skilled and highly experienced. She is deeply engaged in the cases handled by her team, stimulating excellence. Her team has a strong “can-do” approach.’ ‘Marleen van den Horst is incredibly well connected and respected, a skillful strategist and great person to work with’.” – Legal 500, 2021
“Marleen Van den Horst routinely assists a clientele drawn from the pharmaceutical industry with patent infringement and invalidity cases. Clients rate the direction she brings to projects, one suggesting that “she is well organised and able to strategise cases well.”– Chambers Global & Europe, 2021
- Marleen is a board member of the NeoKidney Foundation for the realisation of a wearable artificial kidney. She provides pro bono advice on patent and other legal issues.
- Marleen is a member of several professional organisations and trade associations, such as EPLAW, AIPPI, LES, VF&R and VIEPA.
- She is frequently asked as a speaker at international conferences, such as ERA’s annual EU Pharmaceutical law Conference, Fordham University’s annual IP Conference, World IP Forum, LESI and EPLAW.